Company: Cvs Corp.

CVS

Stock Code:

Enter Stock Code:

This report provides insider trading pattern and statistics for "Cvs Corp. (CVS)" . Please read important descriptions at the bottom of this report.

Register Free Insider Trade Email Alert for "Cvs Corp. (CVS)" !



 

Analysis & Screening

Chart Screening Tool

  Transaction Date

  Filing Date

Start Date:

Select Start Date

End Date:

Select End Date

Trading History Screening Tool

Transaction Code:

Ownership:

Share Class:

Trade Price From:

to

Transaction History From March 22nd, 2017 To April 22nd, 2017 (Max 50 Records Displayed)

Filing Date

Trade Date

 

Insider Name

Event Code

Ownership

Trade Information

Holding % Change

Apr 04/17

Apr 03/17

First-Class Insider Buy

MERLO LARRY J

President and CEO

A

Direct ownership

Acquired 338,105 Stock Option at $78.05

0.00%

Apr 04/17

Apr 03/17

CxO Buy

GOLD STEPHEN J

EVP & CIO

A

Direct ownership

Acquired 8,648 Common Stock (restricted) at $78.05

22.66%

Apr 04/17

Apr 03/17

CxO Buy

GOLD STEPHEN J

EVP & CIO

A

Direct ownership

Acquired 67,621 Stock Option at $78.05

0.00%

Apr 04/17

Apr 03/17

CxO Buy

Roberts Jonathan C

EVP & Chief Operating Officer

A

Direct ownership

Acquired 25,624 Common Stock (restricted) at $78.05

56.75%

Apr 04/17

Apr 03/17

CxO Buy

Brennan Troyen A

EVP and Chief Medical Officer

A

Direct ownership

Acquired 9,609 Common Stock (restricted) at $78.05

40.24%

Apr 04/17

Apr 03/17

CxO Buy

Brennan Troyen A

EVP and Chief Medical Officer

A

Direct ownership

Acquired 75,134 Stock Option at $78.05

0.00%

Apr 04/17

Apr 03/17

CxO Buy

Denton David M

EVP and CFO

A

Direct ownership

Acquired 12,812 Common Stock (restricted) at $78.05

9.15%

Apr 04/17

Apr 03/17

CxO Buy

Denton David M

EVP and CFO

A

Direct ownership

Acquired 100,179 Stock Option at $78.05

0.00%

Apr 04/17

Apr 03/17

CxO Buy

Moriarty Thomas M

EVP & General Counsel

A

Direct ownership

Acquired 16,015 Common Stock (restricted) at $78.05

57.91%

Apr 04/17

Apr 03/17

CxO Buy

Moriarty Thomas M

EVP & General Counsel

A

Direct ownership

Acquired 125,224 Stock Option at $78.05

0.00%

Apr 04/17

Apr 03/17

CxO Buy

Foulkes Helena

EVP, President-CVS Pharmacy

A

Direct ownership

Acquired 19,218 Common Stock (restricted) at $78.05

60.11%

Apr 04/17

Apr 03/17

CxO Buy

Foulkes Helena

EVP, President-CVS Pharmacy

A

Direct ownership

Acquired 150,268 Stock Option at $78.05

0.00%

Apr 04/17

Apr 03/17

CxO Buy

Roberts Jonathan C

EVP & Chief Operating Officer

A

Direct ownership

Acquired 200,358 Stock Option at $78.05

0.00%

Apr 04/17

Apr 03/17

First-Class Insider Buy

MERLO LARRY J

President and CEO

A

Direct ownership

Acquired 43,241 Common Stock (restricted) at $78.05

30.69%

Apr 04/17

Apr 03/17

CxO Buy

Bisaccia Lisa

EVP and Chief HR Officer

A

Direct ownership

Acquired 55,098 Stock Option at $78.05

0.00%

Apr 04/17

Apr 03/17

CxO Buy

Bisaccia Lisa

EVP and Chief HR Officer

A

Direct ownership

Acquired 7,046 Common Stock (restricted) at $78.05

43.93%

Apr 04/17

Apr 03/17

CxO Buy

Sussman Andrew

EVP, Clinical Services

A

Direct ownership

Acquired 37,567 Stock Option at $78.05

0.00%

Apr 04/17

Apr 03/17

CxO Buy

Boratto Eva C

EVP, Cont & Chief Acct Officer

A

Direct ownership

Acquired 4,484 Common Stock (restricted) at $78.05

40.07%

Apr 04/17

Apr 03/17

CxO Buy

Joyner J. David

EVP, Sales & Account Services

A

Direct ownership

Acquired 35,062 Stock Option at $78.05

0.00%

Apr 04/17

Apr 03/17

CxO Buy

Sussman Andrew

EVP, Clinical Services

A

Direct ownership

Acquired 4,804 Common Stock (restricted) at $78.05

41.31%

Apr 04/17

Apr 03/17

CxO Buy

Boratto Eva C

EVP, Cont & Chief Acct Officer

A

Direct ownership

Acquired 35,062 Stock Option at $78.05

0.00%

Apr 04/17

Apr 03/17

CxO Buy

Joyner J. David

EVP, Sales & Account Services

A

Direct ownership

Acquired 4,484 Common Stock (restricted) at $78.05

38.89%

Apr 04/17

Apr 03/17

CxO Buy

Kraft Robert O.

EVP and President - Omnicare

A

Direct ownership

Acquired 5,124 Common Stock (restricted) at $78.05

5.87%

Apr 04/17

Apr 03/17

CxO Buy

Kraft Robert O.

EVP and President - Omnicare

A

Direct ownership

Acquired 40,071 Stock Option at $78.05

0.00%

Apr 04/17

Apr 02/17

CxO Sell

Roberts Jonathan C

EVP & Chief Operating Officer

F

Direct ownership

Disposed -4,655 Common Stock at $78.50

-12.10%

Apr 04/17

Apr 02/17

First-Class Insider Sell

MERLO LARRY J

President and CEO

F

Direct ownership

Disposed -19,944 Common Stock at $78.50

-5.98%

Apr 04/17

Apr 02/17

CxO Sell

Foulkes Helena

EVP, President-CVS Pharmacy

F

Direct ownership

Disposed -2,394 Common Stock at $78.50

-5.05%

Apr 04/17

Apr 02/17

CxO Sell

Joyner J. David

EVP, Sales & Account Services

F

Direct ownership

Disposed -1,862 Common Stock at $78.50

-2.50%

Apr 04/17

Apr 02/17

CxO Sell

Denton David M

EVP and CFO

F

Direct ownership

Disposed -6,649 Common Stock at $78.50

-3.88%

Apr 04/17

Apr 02/17

CxO Sell

Bisaccia Lisa

EVP and Chief HR Officer

F

Direct ownership

Disposed -1,862 Common Stock at $78.50

-3.97%

Apr 04/17

Apr 02/17

CxO Sell

Sussman Andrew

EVP, Clinical Services

F

Direct ownership

Disposed -1,596 Common Stock at $78.50

-12.04%

Apr 04/17

Apr 02/17

CxO Sell

Brennan Troyen A

EVP and Chief Medical Officer

F

Direct ownership

Disposed -3,990 Common Stock at $78.50

-4.92%

Apr 04/17

Apr 01/17

CxO Sell

GOLD STEPHEN J

EVP & CIO

F

Direct ownership

Disposed -1,396 Common Stock at $78.50

-4.56%

Apr 04/17

Apr 01/17

CxO Sell

Bisaccia Lisa

EVP and Chief HR Officer

F

Direct ownership

Disposed -1,291 Common Stock at $78.50

-2.68%

Apr 04/17

Apr 01/17

First-Class Insider Sell

MERLO LARRY J

President and CEO

F

Direct ownership

Disposed -12,906 Common Stock at $78.50

-3.73%

Apr 04/17

Apr 01/17

CxO Sell

Joyner J. David

EVP, Sales & Account Services

F

Direct ownership

Disposed -847 Common Stock at $78.50

-1.12%

Apr 04/17

Apr 01/17

CxO Sell

Denton David M

EVP and CFO

F

Direct ownership

Disposed -2,420 Common Stock at $78.50

-1.39%

Apr 04/17

Apr 01/17

CxO Sell

Brennan Troyen A

EVP and Chief Medical Officer

F

Direct ownership

Disposed -2,097 Common Stock at $78.50

-2.52%

Apr 04/17

Apr 01/17

CxO Sell

Boratto Eva C

EVP, Cont & Chief Acct Officer

F

Direct ownership

Disposed -2,705 Common Stock at $78.50

-6.56%

Apr 04/17

Apr 01/17

CxO Sell

Sussman Andrew

EVP, Clinical Services

F

Direct ownership

Disposed -1,129 Common Stock at $78.50

-7.85%

Apr 04/17

Apr 01/17

CxO Sell

Moriarty Thomas M

EVP & General Counsel

F

Direct ownership

Disposed -2,617 Common Stock at $78.50

-8.30%

Company: Cvs Corp.

CVS

Stock Code:

Chart and trading summary tables represent transactions by company directors, chief executives(CEO, CFO, and senior company officers), corporate substantial shareholders, director's/executive's interest in affiliates of listed corporates, and individual substantial shareholders. Data on this page include all "Cvs Corp. (CVS)" securities traded or transferred within the specified date range defined in stock screening and analysis panel beside the chart. (Note that, not all corporate insiders will record their trading price or number of shares bought/sold in their filings. The missing data are not included in the trading summary calculation). Different insider symbols in the price chart represent transaction activities on a particular date (Not Stock Trading Price). Additionally, transaction price in chart and trading summary table are adjusted for foreign currency exchange rate on the best efforts. The trading summary in net stock buying or stock selling totals are done on a best efforts basis. All data presented should be treated as estimates as it is based on insider trade filings which are subject to errors if input mistakes are made by a filers. Mouse over on signals to see the transaction details in the transaction info box. The chart is optimized for IE5 or above.

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.